Angiotensin-converting enzyme inhibition, intracellular Na+, and Na(+)-K+ pumping in cardiac myocytes
- PMID: 7864075
- DOI: 10.1152/ajpcell.1995.268.2.C366
Angiotensin-converting enzyme inhibition, intracellular Na+, and Na(+)-K+ pumping in cardiac myocytes
Abstract
Angiotensin-converting enzyme (ACE) inhibitors can reduce cardiac mass in both clinical and experimental cardiac hypertrophy. Because cytoplasmic Na+ and pH have been implicated as regulators of cell growth, we examined the effect of treatment with an ACE inhibitor on intracellular Na+ activity (alpha iNa) and pH (pHi) in the heart. After treatment of rabbits with captopril for 8 days alpha iNa was reduced relative to controls (3.6 +/- 0.4, n = 8, vs. 8.2 +/- 0.4 mM, n = 9, P < 0.001), whereas pHi was unchanged. To account for the difference in alpha iNa we measured electrogenic Na(+)-K+ pump activity in single isolated myocytes. Treatment with captopril increased pump currents at near-physiological levels of intracellular Na+ but had no effect at near-saturating levels of Na+. A similar increase in Na(+)-K+ pump activity occurred in rabbits treated with another ACE inhibitor, enalapril, but not with the vasodilator, hydralazine. We speculate that a decrease in alpha iNa after treatment with captopril may contribute to the well-documented ability of ACE inhibitors to reduce cardiac mass.
Similar articles
-
Angiotensin regulates the selectivity of the Na+-K+ pump for intracellular Na+.Am J Physiol. 1999 Sep;277(3):C461-8. doi: 10.1152/ajpcell.1999.277.3.C461. Am J Physiol. 1999. PMID: 10484333
-
Angiotensin-converting enzyme inhibitors regulate the Na(+)-K+ pump via effects on angiotensin metabolism.Am J Physiol. 1996 Jul;271(1 Pt 1):C172-80. doi: 10.1152/ajpcell.1996.271.1.C172. Am J Physiol. 1996. PMID: 8760043
-
Protein kinase Cepsilon contributes to regulation of the sarcolemmal Na(+)-K(+) pump.Am J Physiol Cell Physiol. 2001 Sep;281(3):C1059-63. doi: 10.1152/ajpcell.2001.281.3.C1059. Am J Physiol Cell Physiol. 2001. PMID: 11502584
-
Redox-dependent regulation of the Na⁺-K⁺ pump: new twists to an old target for treatment of heart failure.J Mol Cell Cardiol. 2013 Aug;61:94-101. doi: 10.1016/j.yjmcc.2013.05.013. Epub 2013 May 30. J Mol Cell Cardiol. 2013. PMID: 23727392 Review.
-
Electrophysiology of the sodium-potassium-ATPase in cardiac cells.Physiol Rev. 2001 Oct;81(4):1791-826. doi: 10.1152/physrev.2001.81.4.1791. Physiol Rev. 2001. PMID: 11581502 Review.
Cited by
-
The nitric oxide donor sodium nitroprusside stimulates the Na+-K+ pump in isolated rabbit cardiac myocytes.J Physiol. 2005 Jun 15;565(Pt 3):815-25. doi: 10.1113/jphysiol.2005.086447. Epub 2005 Apr 7. J Physiol. 2005. PMID: 15817632 Free PMC article.
-
Extracellular allosteric Na(+) binding to the Na(+),K(+)-ATPase in cardiac myocytes.Biophys J. 2013 Dec 17;105(12):2695-705. doi: 10.1016/j.bpj.2013.11.004. Biophys J. 2013. PMID: 24359741 Free PMC article.
-
Localization of alpha 1,2,3-subunit isoforms of Na,K-ATPase in cultured neonatal and adult rat myocardium: the immunofluorescence and immunocytochemical study.Mol Cell Biochem. 1996 Oct-Nov;163-164:39-45. doi: 10.1007/BF00408639. Mol Cell Biochem. 1996. PMID: 8974038
-
Protein kinase-dependent oxidative regulation of the cardiac Na+-K+ pump: evidence from in vivo and in vitro modulation of cell signalling.J Physiol. 2013 Jun 15;591(12):2999-3015. doi: 10.1113/jphysiol.2013.252817. Epub 2013 Apr 15. J Physiol. 2013. PMID: 23587884 Free PMC article.
-
The Na+/K+-ATPase: A potential therapeutic target in cardiometabolic diseases.Front Endocrinol (Lausanne). 2023 Feb 28;14:1150171. doi: 10.3389/fendo.2023.1150171. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36926029 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
